Korus™: Transforming T Cell Manufacturing via Elutriation 

Manufacturing autologous T-cell therapies poses a number of challenges, such as working with inconsistent starting material due to variable cell populations. Korus’™ elutriation protocol could help increase the purity of desired cell populations to improve downstream processing.

This study compares Korus elutriation vs conventional washing and the impact on downstream unit operations.

This paper reviews:

• Korus elutriation efficiency
• Downstream manufacturing performance following elutriation
• Comparison between Korus elutriation and conventional washing on downstream performance